Cargando…
Pricing and Reimbursement Pathways of New Orphan Drugs in South Korea: A Longitudinal Comparison
This study aimed to analyze four current pathways affecting the listing and post-listing prices of new orphan drugs (ODs) in South Korea. These mechanisms were: (1) essential OD, (2) pharmacoeconomic evaluation (PE) waiver OD, (3) weighted average price OD, and (4) PE OD. We analyzed the ratio of th...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8000795/ https://www.ncbi.nlm.nih.gov/pubmed/33800373 http://dx.doi.org/10.3390/healthcare9030296 |